Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.

Federal funding for mental health and addiction treatment programs will continue after the Trump administration abruptly reversed a plan to end nearly $2 billio ...

Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.

Researchers evaluated the impact of a 3-month resistance exercise program on exercise capacity and HRQOL in adults with ...

An innovative staffing schedule allots time for clinic staff to complete all expected tasks, easing the stress of clinic visits for both patients and nurses.

HealthDay News — Psychological distress is common among geriatric surgery patients, and greater preoperative stressor counts ...

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Adolescent-onset anorexia nervosa is associated with significantly lower likelihood of full-time employment over a 30-year period, higher long-term health care utilization, and increased reliance on ...

(HealthDay News) — There is variability in risk for hypertensive disorders of pregnancy (HDPs) observed across Asian American, Native Hawaiian, and Pacific Islander subpopulations, according to a ...

Despite growing awareness, many clinicians remain reluctant to screen for trauma, according to Dr Melinyshyn. Concerns like ...